GLUC Revenue third quarter 2017 Y/Y Growth Comment
Glucose Health, Inc. in the third quarter 2017 achieved Revenue of $ 0.02 millions compare to recorded in same quarter a year ago.
Looking into third quarter 2017 results within Biotechnology & Pharmaceuticals industry 34 other companies have achieved higher Revenue growth. While Glucose Health, Inc.' s Revenue no change of 0% ranks overall at the positon no. 2794 in the third quarter 2017.
Revenue by Quarter for the Fiscal Years 2014, 2015, 2016, 2017
Glucose Health,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
125.31 %
47.58 %
-30.14 %
(Jun 30 2017)
GLUC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2017 Glucose Health, Inc. disclosed fall in Revenue from the second quarter by -20.72% to $ 0.02 millions, from $ 0.03 millions achived in the previous reporting period.
Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Glucose Health,'s Revenue growth quarter on quarter, overall rank is 3765.
In the III. Quarter 2017 Glucose Health, Inc. disclosed fall in Revenue from the second quarter by -20.72% to $ 0.02 millions, from $ 0.03 millions achived in the previous reporting period.
Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Glucose Health,'s Revenue growth quarter on quarter, overall rank is 3765.
Glucose Health,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2017)
12 Months Ending (Jun 30 2017)
12 Months Ending (Mar 31 2017)
12 Months Ending (Dec 31 2016)
12 Months Ending (Sep 30 2016)
Cumulative Revenue 12 Months Ending
$ 0.09
$ 0.07
$ 0.33
$ 0.31
$ 0.30
Y / Y Revenue Growth (TTM)
-70.59 %
-77.82 %
7415.91 %
-
-
Year on Year Revenue Growth Overall
Ranking
# 5
# 0
# 0
# 0
#
Seqeuential Revenue Change (TTM)
32.61 %
-79.75 %
4.79 %
4.52 %
0.02 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2794
# 0
# 0
# 0
#
Cumulative Revenue growth Comment
Glucose Health, showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2017. If the fiscal year would end in Sep 30 2017, Glucose Health,'s annual Revenue improvement would be -70.59% year on year to $0 millions.
Glucose Health, Inc. achieved highest trailing twelve month year on year Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 5.
Glucose Health, showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2017. If the fiscal year would end in Sep 30 2017, Glucose Health,'s annual Revenue drop would be -70.59% year on year to $0 millions.
Glucose Health, Inc. achieved highest trailing twelve month year on year Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 5.
About Glucose Health, Revenue Growth Rates (GLUC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
0.00%